All Updates

All Updates

icon
Filter
Listing
Funding
Agrify terminates warrant inducement transaction; receives Nasdaq notification of non-compliance
Vertical Farming
Apr 24, 2023
This week:
Funding
EKORE raises EUR 1.3 million (~ USD 1 million) in seed funding to strengthen platform
Digital Twin
Dec 20, 2024
Funding
Culina Health raises USD 7.9 million in Series A funding to expand offerings and expand team
Functional Nutrition
Dec 19, 2024
FDA approval
ViGeneron receives IND clearance for VG801 gene therapy
Cell & Gene Therapy
Dec 19, 2024
Product updates
Reflex Aerospace ships first commercial satellite SIGI
Next-gen Satellites
Dec 19, 2024
Partnerships
Vast partners with SpaceX for two private astronaut missions to ISS
Space Travel and Exploration Tech
Dec 19, 2024
Management news
Carbios appoints Philippe Pouletty as interim CEO amid plant delay
Waste Recovery & Management Tech
Dec 19, 2024
Funding
BlueQubit raises USD 10 million in seed funding to develop quantum platform
Quantum Computing
Dec 19, 2024
FDA approval
Arbor Biotechnologies receives FDA clearance for ABO-101 IND application
Human Gene Editing
Dec 19, 2024
Funding
Partnerships
Personalis partners with Merck and Moderna for cancer therapy development and investment
Precision Medicine
Dec 19, 2024
Partnerships
COTA partners with Guardant Health to develop clinicogenomic data solutions for cancer research
Precision Medicine
Dec 19, 2024
Vertical Farming

Vertical Farming

Apr 24, 2023

Agrify terminates warrant inducement transaction; receives Nasdaq notification of non-compliance

Listing
Funding

  • Agrify, a Nasdaq-listed company offering vertical farming solutions, has decided not to proceed with a warrant inducement transaction previously announced on April 19, 2023, which would have resulted in gross proceeds of up to USD 1.84 million and the issuance of approximately 21.3 million new warrants to exercising warrant holders. 

  • The decision was made because the transaction would not be in the best interests of its stockholders, partly due to limitations on Agrify’s ability to use its shelf registration statement. The exercise price reduction of warrants issued in Agrify’s December 2022 public offering to USD 0.1725 per share will remain effective, and Agrify plans to explore alternative options for raising capital.

  • Agrify has also received a letter from Nasdaq indicating non-compliance with Nasdaq Listing Rule 5250(c)(1) because it failed to file its annual report on Form 10-K with the SEC for the fiscal year ended December 31, 2022. Although this has no immediate effect on the stock's Nasdaq listing, Agrify may face delisting if it does not regain compliance in a timely manner.

  • Agrify had errors in accounting for warrants and will restate its financial statements, causing a delay in filing its Form 10-K for the fiscal year ended December 31, 2022. The company has until June 20, 2023, to submit a plan to regain compliance with the Nasdaq Listing Rule. If Nasdaq accepts the plan, Agrify may have up to 180 days to regain compliance. If not, Agrify can appeal the decision to a Nasdaq Hearings Panel.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.